• العربية
    • Biotricity, Healthcare

    Biotricity’s path towards breakeven accelerated by latest diagnostic product, Biotres Pro, garnering rapid interest from existing and new customers

    April 26, 2024

    Biotricity Inc. (Biotricity) announces high demand for its latest breakthrough device, Biotres Pro. This device is easy to wear, resulting in excellent patient compliance and a higher selling price. Biotres Pro is expected to raise the average subscription price by over 32%.

    Recent Posts

    Recent Comments

    No comments to show.
    Recent Posts
    Archives
    Categories
    Meta
    Previous
    Biotricity expands market reach to pulmonary and neurology fields through latest partnerships with two leading home-based diagnostic companies
    Next
    Biotricity launches major cardiac monitoring pilot program in a hospital system comprised of 9 hospitals and 10 clinics
    Privacy Settings
    We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
    Youtube
    Consent to display content from - Youtube
    Vimeo
    Consent to display content from - Vimeo
    Google Maps
    Consent to display content from - Google
    Spotify
    Consent to display content from - Spotify
    Sound Cloud
    Consent to display content from - Sound
    Save